ARCHIVES

MicroRNA Assay Detects Cancer Two Years Before LDCT in Study

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

John Ultmann, Chicago’s Outspoken Director, Heads In Retirement

August 30, 1991

Competition For Center Grants Higher In FY95, Kimes Tells BSC

November 25, 1994

AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier

September 26, 1986

Carmona’s Term as Surgeon General Expires.

August 4, 2006

Rauscher “Identifies” Four More Comprehensive Centers

June 21, 1974

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005